Navigation Links
Transave Completes Enrollment in Arikace(TM) Phase II Bronchiectasis Study
Date:4/21/2009

Presently No Approved Treatments

MONMOUTH JUNCTION, N.J., April 21 /PRNewswire/ -- Transave, Inc., today reported completion of patient enrollment in a Phase II study evaluating the safety and efficacy of Arikace(TM) (liposomal amikacin for inhalation) in non-cystic fibrosis (CF) bronchiectasis patients. The results, which are expected to be available by mid-year, will shed new light on how this patient population responds to treatment. Presently, there are no approved treatments for the disease.

"Today's announcement marks the achievement of yet another important milestone in the development of Arikace for chronic lung infections," said Tim Whitten, Transave's Chief Executive Officer. "We believe Arikace has the potential to be an important new treatment for non-CF patients with bronchiectasis. We look forward to seeing the Phase II results in June and moving to Phase III as soon as possible."

The double-blind, placebo-controlled study is designed to evaluate Arikace in non-CF patients who have bronchiectasis with Pseudomonas lung infections. In the trial, 64 adult patients were randomized 2:1 to Arikace - either a 280 mg or a 560 mg dose - or placebo for 28 days, followed by a 28-day off-treatment observation period. Arikace and placebo are administered once daily using an Investigational eFlow(R) Nebulizer System (PARI Pharma GmbH), a novel, highly efficient, portable aerosol delivery system. Sixteen clinical sites throughout Europe and India are participating in the study.

Bronchiectasis is characterized by localized, irreversible enlargement of the bronchial tubes. Involved bronchi are dilated, inflamed, and easily collapsible, resulting in airflow obstruction and impaired clearance of secretions. The accumulation of mucus in the bronchi leads to frequent infections, which further reduce lung function in these patients. One of the m
'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... September 15, 2014 Ondine Biomedical ... Loebel, its President and Chief Technology Officer, will ... Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. ... Brixen/Bressanone (Italy) from October 14-18, 2014 alongside the ... on October 13-14th, is an annual conference at ...
(Date:9/15/2014)... Octo Consulting Group, a leading provider ... federal government, today announced it is opening two ... to better serve existing and future federal government ... to the strong growth momentum of the company’s ... consulting, agile software development, data visualization, and data ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Ohio (PRWEB) September 15, 2014 In ... math and medicine often act conjointly to quantify, define ... industry has become an integral part of medical care. ... regularly reports the studies conducted by the non-profit Institute ... have consistently demonstrated that math can be much more ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... severe respiratory virus believed to have sickened hundreds of ... spread to the Northeast, health officials report. The ... more than a dozen cases of infection with Enterovirus ... asthma. And on Saturday, the Connecticut Department of ...
Breaking Medicine News(10 mins):Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3
... CA (June 18, 2010) Leading academic and professional ... online resource that will put the spotlight on research ... http://www.sagepub.com/sageinsight ) links to highly topical articles from across ... SAGE Journals Online. Drawn from both new and archive ...
... ... Pharmaceutical Business , ... York, NY (PRWEB) June 18, 2010 -- LaVoie Group, a leader in life sciences and ... Mr. Pilato will be based in New York, NY and will lead one of ...
... ... issued proceedings against Godstone farm on behalf of Todd and Aaron Furnell, twins exposed to ... ... LLP has today issued proceedings against Godstone farm on behalf of Todd and Aaron Furnell, ...
... 2010: Two separate studies have shown that vitamin D ... diseases, with over half of all patients having below the ... bodies. A further study assessing response to vitamin D ... normalise vitamin D levels in rheumatic disease patients. The results ...
... 2010: The effects of Systemic Lupus Erythematosus (SLE) may ... to results of a new study presented today at ... Against Rheumatism in Rome, Italy. In particular, the study ... Southern European subpopulations. Results from a Europe-wide study, ...
... ... Plumbing service and heating and air conditioning options for homeowners in ... have increased with the arrival of Berkey’s Plumbing, Heating and Air ... expanding its service area into Irving, Haltom City, Euless, Pantego, Hurst, ...
Cached Medicine News:Health News:LaVoie Group Adds Carey Pilato As Vice President Based In New York 2Health News:Vitamin D deficiency confirmed as common across a range of rheumatic conditions 2Health News:Vitamin D deficiency confirmed as common across a range of rheumatic conditions 3Health News:Berkey's Heating and Air Conditioning, Plumbing Service Now in Central DFW Area 2Health News:Berkey's Heating and Air Conditioning, Plumbing Service Now in Central DFW Area 3Health News:Berkey's Heating and Air Conditioning, Plumbing Service Now in Central DFW Area 4
(Date:9/15/2014)... LAKE CITY , Sept. 15, 2014 /PRNewswire/ ... solutions to the medical device market, announced its ... of Biomerics Advanced Catheter Division. The new division was ... invasive surgical device solutions for the structure heart, ... Biomerics Advanced Catheter will be ...
(Date:9/15/2014)... 2014 Chek Diagnostics, the U.S.-based manufacturer of ... point-of-care diagnostic products, has again been named to the ... companies in America. The Inc. 5000 ranking ... Chek Diagnostics earned its place on the list by ... 2013. For Chek Diagnostics, who appears on ...
(Date:9/15/2014)...  The Female Health Company (NASDAQ-CM: FHCO) today announced ... management team as Executive Vice President of Global Operations ... Michael Pope will retire from his position ... 15, 2014.  Following his retirement, Mr. Pope will continue ... Prior to joining The Female Health Company (FHC), ...
Breaking Medicine Technology:Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 3
Inquire...
... of electronic refractors. The TRS replaces your standard ... a keypad that is small enough to sit in ... Chart Projector. The TRS is programmable so that at ... moved for you, taking you to your next refraction ...
Uniquely designed, the wheelchair table has dual purposes. Not only does it add a modern look to any office, it is also a heavy-duty table that will support multiple instruments, and/or easily accomm...
... Ideal for satellite clinics or for ... value, the Debut stand is an ... construction and molded composite body offer ... counterbalanced slit-lamp arm--one of two arms ...
Medicine Products: